- Stanford rTMS that reaches 90% remission rate in Major Depression Treatment revised in double blind placebo study: https://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.2021.20101429 2 comments science
- Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial https://doi.org/10.1176/appi.ajp.2021.20101429 7 comments science
Linking pages
- 'It Saved My Life': Depression Treatment Is Turning Lives Around in Five Days | KQED https://www.kqed.org/news/11898991/it-saved-my-life-depression-treatment-turns-lives-around-in-five-days 331 comments
- Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression | American Journal of Psychiatry https://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.2019.19070720 142 comments
- New Treatment For Depression Causes Remission In Almost 80 Percent Of Patients | IFLScience https://www.iflscience.com/health-and-medicine/new-treatment-for-depression-causes-remission-in-almost-80-percent-of-patients/ 41 comments
- Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial | American Journal of Psychiatry https://doi.org/10.1176/appi.ajp.2021.20101429 9 comments
- Depression responds to transcranial magnetic stimulation treatment in studies : Shots - Health News : NPR https://www.npr.org/sections/health-shots/2022/02/06/1074719132/an-experimental-depression-treatment-uses-electric-currents-to-bring-relief 0 comments
Related searches:
Search whole site: site:ajp.psychiatryonline.org
Search title: Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial | American Journal of Psychiatry
See how to search.